BCL2 and sarcoma: This analysis revealed that BCL2 mRNA levels are overexpressed in CDS tumors compared to other sarcoma subtypes and to a range of normal tissues (Supplementary Fig. S7a-b), in agreement with a case study showing high BCL2 protein expression in a CDS tumor41.